Bausch + Lomb Q1 Earnings Forecast Boosted by HC Wainwright

Posted by Geri Gentry on Nov 3rd, 2026

Bausch + Lomb Corporation (NYSE:BLCO – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2027 earnings per share (EPS) estimates for shares of Bausch + Lomb in a report released on Monday, November 2nd. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings of $0.16 per share for the quarter, up from their previous forecast of $0.12. HC Wainwright currently has a “Neutral” rating and a $22.00 price target on the stock. The consensus estimate for Bausch + Lomb’s current full-year earnings is $0.94 per share. HC Wainwright also issued estimates for Bausch + Lomb’s Q2 2027 earnings at $0.29 EPS.

Bausch + Lomb (NYSE:BLCO – Get Free Report) last posted its earnings results on Wednesday, October 28th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.13. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.37 billion. Bausch + Lomb had a positive return on equity of 5.02% and a negative net margin of 2.05%. Bausch + Lomb’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 EPS.

Several other equities analysts also recently issued reports on the stock. Royal Bank Of Canada upped their price objective on shares of Bausch + Lomb from $21.00 to $23.00 and gave the company an “outperform” rating in a research note on Thursday, October 29th. Barclays raised shares of Bausch + Lomb to a “strong-buy” rating in a research note on Wednesday, October 7th. Wall Street Zen upgraded Bausch + Lomb from a “buy” rating to a “strong-buy” rating in a report on Saturday. UBS Group started coverage on Bausch + Lomb in a research note on Thursday, July 30th. They set a “buy” rating and a $21.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $20.00 price target on shares of Bausch + Lomb in a research note on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $20.83.

Check Out Our Latest Analysis on Bausch + Lomb

Bausch + Lomb Price Performance

Bausch + Lomb stock opened at $20.07 on Tuesday. Bausch + Lomb has a 12-month low of $14.44 and a 12-month high of $21.36. The stock has a market capitalization of $7.17 billion, a P/E ratio of -64.76, a P/E/G ratio of 0.64 and a beta of 0.56. The firm’s 50-day moving average is $17.41 and its two-hundred day moving average is $16.70. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.55 and a quick ratio of 1.02.

Insiders Place Their Bets

In other news, CAO Frederick Munsch sold 112,015 shares of Bausch + Lomb stock in a transaction dated Thursday, October 29th. The stock was sold at an average price of $20.48, for a total value of $2,294,067.20. Following the transaction, the chief accounting officer directly owned 45,831 shares of the company’s stock, valued at $938,618.88. The trade was a 70.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Eschenbach Andrew C. Von sold 6,059 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $16.58, for a total value of $100,458.22. Following the sale, the director owned 63,733 shares of the company’s stock, valued at $1,056,693.14. The trade was a 8.68% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 183,474 shares of company stock valued at $3,488,437. Insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of BLCO. Engineers Gate Manager LP acquired a new stake in Bausch + Lomb in the 2nd quarter valued at $1,479,000. Beach Point Capital Management LP purchased a new position in Bausch + Lomb in the third quarter valued at about $5,882,000. Whitebox Advisors LLC raised its position in Bausch + Lomb by 15.8% in the first quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company’s stock valued at $17,519,000 after purchasing an additional 150,641 shares during the period. Sei Investments Co. lifted its stake in shares of Bausch + Lomb by 100.0% during the first quarter. Sei Investments Co. now owns 139,266 shares of the company’s stock worth $2,214,000 after purchasing an additional 69,633 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC acquired a new position in shares of Bausch + Lomb during the third quarter worth about $670,000. Hedge funds and other institutional investors own 11.07% of the company’s stock.

More Bausch + Lomb News

Here are the key news stories impacting Bausch + Lomb this week:

Positive Sentiment: Strong-buy and momentum rankings: Zacks added BLCO to its Rank #1 (Strong Buy) lists for both momentum and overall stock selection. Zacks also identified the company as a potential long-term value stock, which may attract growth and value-oriented investors. Best Momentum Stock to Buy for November 2nd Why Bausch + Lomb Is a Top Value Stock
Positive Sentiment: Higher consensus valuation: The consensus price target reportedly increased 10.44% to $21.92, suggesting analysts see additional upside from recent trading levels. Bausch + Lomb Consensus Price Target Raised
Positive Sentiment: Operating momentum: Highlights from BLCO’s third-quarter earnings call emphasized strong growth. The company previously reported revenue growth of 7.3% year over year and earnings that exceeded analyst expectations, supporting the bullish case. Bausch + Lomb Earnings Call Highlights Strong Growth
Neutral Sentiment: Mixed analyst signal: HC Wainwright raised its price target to $22 from $21 but downgraded BLCO from Buy to Neutral, indicating improved valuation expectations but less conviction that the stock will materially outperform. HC Wainwright Downgrades Bausch + Lomb
Negative Sentiment: Insider selling: Chief Accounting Officer Frederick Munsch sold 112,015 shares worth approximately $2.29 million, reducing his holdings by about 71%. While insider sales can be routine, the transaction may concern investors because of its size.

About Bausch + Lomb

(Get Free Report)

Bausch + Lomb Corporation (NYSE: BLCO) is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.